Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 5 | 5 |
Avg. Estimate | 0.99 | 1.23 | 4.04 | 4.54 |
Low estimate | 0.99 | 1.19 | 4 | 4.5 |
High estimate | 1 | 1.26 | 4.1 | 4.61 |
Year ago EPS | 0.97 | 1.28 | 3.86 | 4.04 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 3 | 3 | 6 | 6 |
Avg. Estimate | 9.66B | 10.75B | 40.67B | 43.18B |
Low estimate | 9.65B | 10.69B | 40.01B | 42.18B |
High estimate | 9.67B | 10.84B | 41.55B | 44.96B |
Year ago sales | 8.99B | 9.44B | 37.7B | 40.67B |
Sales growth (year/est) | 7.50% | 13.90% | 7.90% | 6.20% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|---|---|---|---|
Est. EPS | 0.87 | 1.14 | 0.76 | 0.91 |
Actual EPS | 0.97 | 1.28 | 0.72 | 1.09 |
Difference | 0.1 | 0.14 | -0.04 | 0.18 |
Surprise % | 11.50% | 12.30% | -5.30% | 19.80% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 0.99 | 1.23 | 4.04 | 4.54 |
7 days ago | 0.98 | 1.23 | 4.09 | 4.64 |
30 days ago | 0.99 | 1.24 | 4.07 | 4.65 |
60 days ago | 0.98 | 1.28 | 4.09 | 4.69 |
90 days ago | 0.94 | 1.28 | 3.96 | 4.49 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | 1 | N/A | N/A | N/A |
Up last 30 days | 1 | N/A | 1 | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | 1 | 2 | 2 |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 2.10% | N/A | N/A | N/A |
Next qtr. | -3.90% | N/A | N/A | N/A |
Current year | 4.70% | N/A | N/A | N/A |
Next year | 12.40% | N/A | N/A | N/A |
Next 5 years (per annum) | 4.80% | N/A | N/A | N/A |
Past 5 years (per annum) | -0.77% | N/A | N/A | N/A |